IMM 1.23% 40.0¢ immutep limited

cure for foot and mouth?, page-2

  1. 345 Posts.
    Prr seem to have been developing nicely and although a biased opinion managemnet claims that the value of their intellectual property far exceeds the current share price.
    Their portfolio of research projects focus on the following areas:
    -technology that has the potential to both prevent and treat Malaria
    -development of tumour antigens to target cancer cells of the breast, lungs, colon, ovaries and prostate
    -development of new drugs for rheumatoid athritis
    -producing an immune response in large animals leading to a vaccination against foot and mouth disease.
    Several licences and royalties in the pipeline with significant announcements due in July. Worth a punt at current levels, who knows how this one may run if any one of their technologies is a hit.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
40.0¢
Change
-0.005(1.23%)
Mkt cap ! $581.0M
Open High Low Value Volume
41.0¢ 41.5¢ 39.5¢ $1.576M 3.906M

Buyers (Bids)

No. Vol. Price($)
1 2506 39.5¢
 

Sellers (Offers)

Price($) Vol. No.
40.0¢ 8079 1
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.